Form 4 for BVS Bioventus Inc.
Accepted 2024-06-18 00:00:00 ET · period of report 2024-06-15 · accession 0001578563-24-000301 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-18 | 2024-06-15 | BVS | D'Adamio Anthony | SVP, GC | M - OptEx | $0.00 | +34.7K | 92.9K | +60% | $0 |
| D | 2024-06-18 | 2024-06-15 | BVS | D'Adamio Anthony | SVP, GC | M - OptEx | $0.00 | -34.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-06-15 | M | A | 34,696 | $0.00 | 92,938 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2024-06-15 | M | D | 34,696 | $0.00 | 0 | D | — · — to — | 34,696 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F2) The RSUs vested on June 15, 2024. |